Amerikanische Gesellschaft für Hirudotherapie

Health Products Regulatory Authority — Ireland

HPRA · Ireland · europe

Regulatory jurisdiction profileJurisdictional reference
Unregulatednational regulator

Ireland's Health Products Regulatory Authority — leeches fall under EU medical-device frameworks (MDR 2017/745) as implemented through Irish national law; leech-specific national authorisation has not been independently verified by ASH.

Regulatory Profile

Agency type
national regulator
Region
europe
Country
Ireland
Leech status
unregulated
Last ASH review
2026-05-27

Relevant Regulation Codes

  • Irish Medicinal Products (Control of Manufacture) Regulations
  • EU Medical Device Regulation (MDR) 2017/745 — as transposed into Irish law (S.I. No. 261/2021)
  • Irish Medical Practitioners Act 2007 (as amended)

Prescriber Requirements

  • Irish Medical Council–registered physician — order required for any biomedical device application
  • Allied health professional application under physician supervision per institutional protocol

Supply Chain & GMP

HPRA registration as applicable; English-language labelling (Irish-language requirements may apply for state-procured devices). Standard cold-chain conditions; EU intra-community movement under MDR applies.

Import/Export Rules

Free movement within the EU single market under MDR; Department of Agriculture, Food and the Marine clearance for live invertebrates from non-EU origin; CITES Appendix II paperwork for Hirudo medicinalis / verbana on extra-EU import.

Reimbursement Context

Health Service Executive (HSE) inpatient bundling generally applies; outpatient hirudotherapy is generally not separately reimbursed under the General Medical Services scheme.

ASH Editorial Notes

Leech-specific pathway not independently verified by ASH; falls under general EU MDR framework as transposed into Irish law. HPRA coordinates with EMA and other EU NCAs; whether leech-specific guidance exists has not been independently mapped by ASH.

Related Jurisdictions

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.